Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection

Published:2019-06-07 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Pan Zhangchi¹,Zhang Lu²,Liu Chen³,Huang Xiaobing¹,Shen Songfei¹,Lin Xiaoyan¹,Shi Chunmei¹

Affiliation:

1. Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China

2. Department of Clinical Laboratories, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, P.R. China

3. Department of Oncology, Fujian Magaw Memorial Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of the advanced lung cancer inflammation index in patients with limited-stage small cell lung cancer treated with chemoradiotherapy;Scientific Reports;2024-05-06

2. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles;Environmental Research;2024-01

3. The prognostic significance of serum lactate dehydrogenase for patients with small cell lung cancer treated first-line therapy: a retrospective analysis of 163 consecutive cases;2023-03-16

4. Pretreament neutrophil-lymphocyte ratio (NLR): A felicitous prognostic marker in carcinoma lung;Journal of Cancer Research and Therapeutics;2023

5. Changes in the neutrophil to lymphocyte ratio as predictors of outcome in pediatric patients with central nervous system tumors undergoing surgical resection;Cancer Biomarkers;2021-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3